JBIO
Jade Biosciences, Inc.
NASDAQ: JBIO · HEALTHCARE · BIOTECHNOLOGY
$24.13
-0.90% today
Updated 2026-06-03
Market cap
$1.01B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.63
Dividend yield
—
52W range
$7 – $28
Volume
0.7M
Jade Biosciences, Inc. (JBIO) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
-67.4%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+91.4%
Most recent quarter
When is the next earnings report?
Reporting date
December 31, 2025
Consensus EPS estimate
$-0.47
Fiscal period ending
2025-12-31
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+4.9%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+7.0%
2025-11-13
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-05-07 | $-0.57 | -18.7% | $25.13 | $25.81 | +2.7% |
| 2025-11-13 | $-0.48 | +28.4% | $10.00 | $10.70 | +7.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | $-0.48 | $-0.57 | -18.7% | — | — |
| 2025-12-31 | $-0.47 | — | — | — | — |
| 2025-09-30 | $-0.67 | $-0.48 | +28.4% | — | — |
| 2025-06-30 | $-0.48 | $-0.86 | -79.2% | — | — |
| 2025-03-31 | $-2.05 | $-12.10 | -490.2% | — | — |
| 2024-12-31 | $-0.40 | $-6.61 | -1542.2% | — | — |
| 2024-09-30 | $-0.58 | $-19.60 | -3274.7% | — | — |
| 2024-06-30 | $-0.85 | $-30.10 | -3441.2% | — | — |
| 2024-03-31 | $-0.76 | $-0.83 | -9.2% | — | — |
| 2023-12-31 | $-0.74 | $-25.90 | -3400.0% | — | — |
| 2023-09-30 | $-0.69 | $-0.71 | -2.9% | — | — |
| 2023-06-30 | $-0.70 | $-0.76 | -8.6% | — | — |
Frequently asked questions
When does Jade Biosciences, Inc. report next earnings?
Jade Biosciences, Inc. (JBIO) is scheduled to report earnings on December 31, 2025. The consensus EPS estimate is $-0.47.
Has Jade Biosciences, Inc. beaten earnings estimates?
Jade Biosciences, Inc. has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports, averaging a -67.4% surprise over the last 4. A consistent beat record suggests management guides conservatively and the business has predictable momentum, which tends to support the stock through earnings season.
How does JBIO stock react to earnings?
JBIO has moved an average of +4.9% the day after earnings over its last 2 reports, finishing higher after 2 of them. Next-day moves show how the market digests results in the short term, and repeated dips on strong reports usually mean expectations were already priced in.